首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

European Journal Of Drug Metabolism And Pharmacokinetics

European Journal Of Drug Metabolism And Pharmacokinetics杂志,由Springer International Publishing出版,于1976年创刊,Quarterly,出版语言English,ISSN:0378-7966,E-ISSN:2107-0180。

投稿咨询
European Journal Of Drug Metabolism And Pharmacokinetics
European Journal Of Drug Metabolism And Pharmacokinetics
European Journal Of Drug Metabolism And Pharmacokinetics
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
2.3
CiteScore
4.9
期刊收录
SCI、SCIE

European Journal Of Drug Metabolism And Pharmacokinetics(中文译名:《欧洲药物代谢和药代动力学杂志》),ISSN:0378-7966,EISSN:2107-0180,是Springer International Publishing出版的国际性学术期刊,创刊于1976年,以Quarterly形式稳定发行,2026年总发文量约42篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.3,2025年期刊CiteScore为4.9,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。European Journal Of Drug Metabolism And Pharmacokinetics长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期>12周,或约稿,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Japan、GERMANY (FED REP GER)、India、Netherlands、England等为核心发文国家与地区;PEKING UNIVERSITYSHANGHAI JIAO TONG UNIVERSITY、UNIVERSITY OF ALBERTA、CHINA PHARMACEUTICAL UNIVERSITY、POZNAN UNIVERSITY OF MEDICAL SCIENCES、ABBVIE、ASTELLAS PHARMACEUTICALS等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 226 / 356

36.7

学科:PHARMACOLOGY & PHARMACY SCIE Q3 218 / 356

38.9

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 231 / 354

34.9

学科:PHARMACOLOGY & PHARMACY SCIE Q3 227 / 354

36.02


中国学者近期发文

1
Optimization of Dosing Regimens for Plasminogen Activation Inhibitor BT-114143 Using a Small Molecule TMDD Population PK and PD Model in Healthy Subject

Author:Li, Min; Li, Yafen; Zeng, Shaomei; Wang, Yaqi; Ji, Yafei; Yang, Guo-Ping; Tang, Jun

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2026; Vol. 51, Issue 2, pp. 217-228. DOI: 10.1007/s13318-026-00987-2

2
Pharmacokinetics and Bioequivalence of Propafenone Hydrochloride Tablets under Fasting Conditions in Healthy Subject

Author:Zhang, Yi; Hua, Meixia; Du, Lijie; Yin, Xianmiao; Gan, Fangliang

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13318-026-00991-6

3
A Validated LC-MS/MS Method for Unbound Rifapentine Quantitation Reveals Nonlinear Plasma Protein Binding and Comparable Free Fractions Between Adults and Children with Tuberculosi

Author:Qiao, Wenmei; Fang, Mutong; Liu, Miaona; He, Tian; Zhang, Peize; Li, Wei

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13318-026-00985-4

4
Bioequivalence and Comparative Pharmacokinetics of Two Generic Mirogabalin Besylate Tablets (5 mg and 10 mg) and Tarlige® in Healthy Chinese Volunteers: A Pooled Analysis of Two Randomized, Open-Label, Two-Period Crossover Studie

Author:Wang, Fengling; Yu, Haitao; Ye, Xi; Wei, Liying; Xiong, Xiaolian; Zhu, Lili; Zheng, Limin; Li, Fan; Wang, Angeng; Li, Chenhui; Meng, Xiangyun

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13318-025-00977-w

5
Minimal Physiologically-Based Pharmacokinetic Modeling to Predict Concentration-Time Profiles of Poorly Soluble Cinacalcet Hydrochloride in Fasting and Fed Stat

Author:Xie, Xiaoqian; Sun, Le

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13318-025-00983-y

6
The Impact of Hyperuricemia on Pharmacokinetics in Sprague-Dawley Rat

Author:Pan, Xiaomeng; Li, Dandan; Chen, Yujuan; Lu, Jiamian; Yang, Yakun; Guo, Yusong; Kong, Dezhi; Guo, Wei

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13318-025-00950-7

7
A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subject

Author:Wang, Ying; Cheng, Yuanzhi; Guo, Yuhan; Fan, Yang; Zhou, Renpeng; Zhang, Qian; Xu, Ye; Feng, Sheng; Shen, Kai; Hu, Wei

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13318-025-00944-5

8
Herb-Drug Interaction of Total Glucosides of Paeony and Tripterygium Glycoside with Celecoxib in Beagle Dogs by UPLC-MS/M

Author:Zhang, Zhifei; Wang, Huijun; Ren, Xinli; Li, Xiaotong; Peng, Xinyu; Qiu, Xiangjun

Journal: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13318-025-00933-8


在线咨询

European Journal Of Drug Metabolism And Pharmacokinetics

国际简称:EUR J DRUG METAB PH参考译名:欧洲药物代谢和药代动力学杂志

年发文量:42 CiteScore:4.9 是否预警:否 Gold OA文章占比:29.41% 研究类文章占比:83.33%

杂志社联系方式:MEDECINE ET HYGIENE, CH DE LA MOUSSE 46, CASE POSTALE 475, CHENE-BOURG, SWITZERLAND, CH-1225

European Journal Of Drug Metabolism And Pharmacokinetics